- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-3329
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma ; volume:2 ; number:1 ; day:24 ; month:1 ; year:2012 ; pages:1-7 ; date:12.2012
Clinical Sarcoma Research ; 2, Heft 1 (24.1.2012), 1-7, 12.2012
- Creator
-
Katz, Daniela
Boonsirikamchai, Piyaporn
Choi, Haeson
Lazar, Alexander J.
Wang, Wei-Lein
Xiao, Lianchun
Park, Min S.
Ravi, Vinod
Benjamin, Robert S.
Araujo, Dejka M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/2045-3329-2-2
- URN
-
urn:nbn:de:101:1-2021081922245295099002
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Katz, Daniela
- Boonsirikamchai, Piyaporn
- Choi, Haeson
- Lazar, Alexander J.
- Wang, Wei-Lein
- Xiao, Lianchun
- Park, Min S.
- Ravi, Vinod
- Benjamin, Robert S.
- Araujo, Dejka M.
- SpringerLink (Online service)
Other Objects (12)
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma
Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicin
The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis
Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopenia
AIH Therapy: Beyond First-Line
Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures
Complete Remission of Recurrent Retroperitoneal Liposarcoma after the Administration of Gemcitabine and Docetaxel as First-Line Adjuvant Chemotherapy: A Case Report
Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?
Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model
Liposarcoma paratesticular gigante
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma
Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicin
The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis
Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopenia
AIH Therapy: Beyond First-Line
Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures
Complete Remission of Recurrent Retroperitoneal Liposarcoma after the Administration of Gemcitabine and Docetaxel as First-Line Adjuvant Chemotherapy: A Case Report
Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?
Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model
Liposarcoma paratesticular gigante
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma
Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicin
The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis
Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopenia
AIH Therapy: Beyond First-Line
Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures
Complete Remission of Recurrent Retroperitoneal Liposarcoma after the Administration of Gemcitabine and Docetaxel as First-Line Adjuvant Chemotherapy: A Case Report
Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?
Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model